tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BDTX Stock Latest News

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
Press ReleasesBlack Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
6d ago
BDTX
Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
BDTX
Black Diamond Therapeutics reports Q2 EPS (36c), consensus (39c)
PremiumThe Fly
Black Diamond Therapeutics reports Q2 EPS (36c), consensus (39c)
1M ago
BDTX
McDonald’s downgraded, PayPal upgraded: Wall Street’s top analyst calls
PremiumThe Fly
McDonald’s downgraded, PayPal upgraded: Wall Street’s top analyst calls
2M ago
GO
ECL
Black Diamond Therapeutics initiated with an Outperform at Raymond James
PremiumThe Fly
Black Diamond Therapeutics initiated with an Outperform at Raymond James
2M ago
BDTX
Black Diamond Therapeutics initiated with an Outperform at Raymond James
PremiumThe FlyBlack Diamond Therapeutics initiated with an Outperform at Raymond James
2M ago
BDTX
Black Diamond Therapeutics management to meet with Piper Sandler
Premium
The Fly
Black Diamond Therapeutics management to meet with Piper Sandler
2M ago
BDTX
Black Diamond presents data from Phase 1 dose escalation trial of BDTX-1535
Premium
The Fly
Black Diamond presents data from Phase 1 dose escalation trial of BDTX-1535
4M ago
BDTX
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4M ago
BDTX
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
PremiumPress Releases
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
4M ago
BDTX
Black Diamond participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Black Diamond participates in a conference call with Cantor Fitzgerald
4M ago
BDTX
Black Diamond participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Black Diamond participates in a conference call with Cantor Fitzgerald
4M ago
BDTX
Black Diamond price target lowered to $11 from $12 at H.C. Wainwright
PremiumThe FlyBlack Diamond price target lowered to $11 from $12 at H.C. Wainwright
4M ago
BDTX
Black Diamond Therapeutics reports Q1 EPS (35c), consensus (43c)
Premium
The Fly
Black Diamond Therapeutics reports Q1 EPS (35c), consensus (43c)
4M ago
BDTX
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4M ago
BDTX
Black Diamond Therapeutics announces changes to board of directors
PremiumThe Fly
Black Diamond Therapeutics announces changes to board of directors
5M ago
BDTX
Black Diamond Therapeutics Revamps Board Leadership
PremiumCompany Announcements
Black Diamond Therapeutics Revamps Board Leadership
5M ago
8K
BDTX
Black Diamond Therapeutics Announces Changes to Board of Directors
PremiumPress Releases
Black Diamond Therapeutics Announces Changes to Board of Directors
5M ago
BDTX
Black Diamond Therapeutics presents preclinical data on BDTX-1535 at AACR
PremiumThe Fly
Black Diamond Therapeutics presents preclinical data on BDTX-1535 at AACR
5M ago
BDTX
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
PremiumPress ReleasesBlack Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
6M ago
BDTX
Black Diamond Therapeutics price target raised to $12 from $11 at H.C. Wainwright
Premium
The Fly
Black Diamond Therapeutics price target raised to $12 from $11 at H.C. Wainwright
6M ago
BDTX
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Premium
Press Releases
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6M ago
BDTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >